Metraipolis › archive › dc_ae66a38726a4

Redefining Difficult-to-Treat Systemic Lupus Erythematosus: Biomarkers of Molecular Refractoriness Beyond Clinical Failure — Europe PMC PMID:42123602

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123602
DOI
10.3390/ijms27094026
License (as archived)
solo-consultazione
Archived
2026-11-03T01:18:53.599Z
SHA-256 of the archived text
79b14904aff7e231139d0b8e8379b145a73d80fa1e6067e12d633b35d74e82e9
Stable URL of this page
https://metraipolis.com/documento/dc_ae66a38726a4

How to cite

Redefining Difficult-to-Treat Systemic Lupus Erythematosus: Biomarkers of Molecular Refractoriness Beyond Clinical Failure — Europe PMC PMID:42123602 — Europe PMC (en), https://europepmc.org/article/MED/42123602 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae66a38726a4 (Metraipolis archive dc_ae66a38726a4, sha256 79b14904aff7e231139d0b8e8379b145a73d80fa1e6067e12d633b35d74e82e9)
BibTeX
@misc{dcae66a38726a4,
  title = {Redefining Difficult-to-Treat Systemic Lupus Erythematosus: Biomarkers of Molecular Refractoriness Beyond Clinical Failure — Europe PMC PMID:42123602},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123602},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae66a38726a4; sha256 79b14904aff7e231139d0b8e8379b145a73d80fa1e6067e12d633b35d74e82e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123602. Agents can read the archived copy with the MCP tool read_document.